Literature DB >> 23473736

Role of ultrasonography in percutaneous renal access in patients with renal anatomic abnormalities.

Necmettin Penbegul1, Namik Kemal Hatipoglu, Mehmet Nuri Bodakci, Murat Atar, Yasar Bozkurt, Ahmet Ali Sancaktutar, Abdulkadir Tepeler.   

Abstract

OBJECTIVE: To present our experience regarding the feasibility, safety, and efficacy of ultrasound (US)-guided percutaneous nephrolithotomy in anatomically abnormal kidneys.
MATERIALS AND METHODS: We performed US-guided percutaneous nephrolithotomy in 15 patients with anatomically abnormal kidneys and renal calculi. Of the 15 patients, 5 had horseshoe kidneys, 5 had rotation anomalies, 2 had kyphoscoliosis, and 3 had scoliosis. The stone size, number of access tracts, operative time, hospitalization duration, rate of stone clearance, and complication rate were recorded. Percutaneous access was achieved with US guidance in the operating room by the urologist.
RESULTS: Successful renal access was obtained by the surgeon using US guidance in all patients, and a single access was obtained in all cases. Of the 15 patients, 8 were females, and 7 were males; 8 patients had solitary stones, and 7 had multiple calculi. The renal calculi were on the right in 7 patients and on the left in 8. Three patients had previously undergone unsuccessful shock wave lithotripsy. Complete stone clearance was achieved in 13 patients. The mean operative time was 54.2 minutes. No patient required a blood transfusion because of bleeding. Urinary tract infections occurred in 2 patients, who were treated with antibiotics. A double-J catheter was not inserted in any patient; however, a ureteral catheter was used in 3 patients for 1 day. None of the patients had any major complications during the postoperative period. The stone-free rate was 87%, and 2 patients had clinically insignificant residual fragments.
CONCLUSION: Our results have demonstrated that US-guided percutaneous nephrolithotomy can be performed feasibly, safely, and effectively in anatomically abnormal kidneys.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23473736     DOI: 10.1016/j.urology.2013.01.038

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Nephrolithometric Scoring Systems to Predict Outcomes of Percutaneous Nephrolithotomy.

Authors:  Simone L Vernez; Zhamshid Okhunov; Piruz Motamedinia; Vincent Bird; Zeph Okeke; Arthur Smith
Journal:  Rev Urol       Date:  2016

2.  Adopting Ultrasound Guidance for Prone Percutaneous Nephrolithotomy: Evaluating the Learning Curve for the Experienced Surgeon.

Authors:  Manint Usawachintachit; Selma Masic; Isabel E Allen; Jianxing Li; Thomas Chi
Journal:  J Endourol       Date:  2016-06-13       Impact factor: 2.942

3.  Bilateral microperc in a severe kyphoscoliosis.

Authors:  Mansur Dağgülli; Necmettin Penbegül; Onur Dede; Mehmet Mazhar Utanğaç
Journal:  Turk J Urol       Date:  2016-03

Review 4.  Predictability and Practicality of Image-Based Scoring Systems for Patient Assessment and Outcome Stratification During Percutaneous Nephrolithotomy: a Contemporary Update.

Authors:  Linda My Huynh; Erica Huang; Roshan M Patel; Zhamshid Okhunov
Journal:  Curr Urol Rep       Date:  2017-10-18       Impact factor: 3.092

Review 5.  Use of Ultrasound in Pediatric Renal Stone Diagnosis and Surgery.

Authors:  Jeffrey C Morrison; Trudy Kawal; Jason P Van Batavia; Arun K Srinivasan
Journal:  Curr Urol Rep       Date:  2017-03       Impact factor: 3.092

6.  Percutaneous nephrolithotomy in horseshoe kidney: comparing ultrasound-guided access in flank position with conventional fluoroscopic-guided in prone position.

Authors:  Seyed Hassan Inanloo; Seyed Reza Yahyazadeh; Mahdi Ramezani-Binabaj
Journal:  Urolithiasis       Date:  2022-10-14       Impact factor: 2.861

7.  Guy's Stone Score (GSS) Based on Intravenous Pyelogram (IVP) Findings Predicting Upper Pole Access Percutaneous Nephrolithotomy (PCNL) Outcomes.

Authors:  Bannakij Lojanapiwat; Pattara Rod-Ong; Pruit Kitirattrakarn; Wilaiwan Chongruksut
Journal:  Adv Urol       Date:  2016-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.